SSSahar Saeed

Sahar Saeed

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sahar Saeed has a total of 330 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    “So much other stuff going on”: Factors influencing syphilis and STBBI testing among street-involved communities in Kingston, Ontario

    by Duy A. Dinh, Lucy Mackrell, Jillian P. Antoun, Megan Carter, Mary Southall, Patrick Sanderson, Maggie Hoover, Sahar Saeed

    Objective: Syphilis is a re-emerging public health threat in Canada, disproportionately affecting street-involved communities. This qualitative study aimed to identify the multilevel factors influencing access to timely syphilis testing among people who are street-involved in Kingston, Ontario. Methods: Using an interpretive description approach, we conducted in-depth, semi-structured interviews with clients of local harm reduction and housing services and focus groups with community-based organization service providers to explore their perspectives surrounding factors influencing syphilis and sexually transmitted and blood-borne infection (STBBI) testing decisions. Interviews were audio-recorded, transcribed, coded using NVivo, and analysed using reflexive thematic analysis within the socio-ecological framework. Results: A total of 23 individuals were included: 16 clients and 7 providers. A majority of clients identified as being un(der)housed ( n = 13) and/or people who use drugs ( n = 10), with a median age of 26 years. At the structural and systems level, institutional broken trust, availability of testing services and information, and transportation emerged as salient factors influencing access to testing. Social- and community-level factors included the influence of trusted providers, close social networks, and privacy and confidentiality. Knowledge level, perceived risk, competing priorities, and testing preferences also influenced testing decision-making. Conclusions: Our findings highlight the complexity of the multilevel factors that influence syphilis testing decisions among street-involved communities. Clients’ and providers’ concordance in their emphasis on socio-structural factors underscores the necessity of shifting the onus of syphilis testing uptake beyond the individual level, and implementing models of care that address barriers and structural interventions that address root causes.

  • Open Access

    Sex differences in mortality risk profiles across the life course in metabolic dysfunction-associated steatotic liver disease: a machine learning analysis of the Canadian Longitudinal Study on Aging

    by Cindy Wen, Wei Tu, Giada Sebastiani, Jessica Burnside, Carmela Rapino, Alnoor Ramji, Mark G. Swain, Keyur Patel, Erica E. M. Moodie, Jennifer A. Flemming, et al.

    Background: Prognostic models for metabolic dysfunction-associated steatotic liver disease (MASLD) are largely ‘one-size-fits-all’ and do not collectively account for sex differences and social determinants of health (SDoH). To address this gap, we trained and developed sex-specific machine learning models that incorporated SDoHs to examine important predictors of all-cause mortality among adults with MASLD. Methods: Using the Canadian Longitudinal Study on Aging, MASLD was defined as the presence of hepatic steatosis, at least one cardiometabolic risk factor, and low levels of sex-specific alcohol consumption (females: < 140 g/week, males: < 210 g/week). Three machine learning models were examined in sex and age-specific subgroups (middle-age: 45–64 years vs. older age: $$\:\ge\:$$ 65 years). Based on the literature, expert input, and data availability, 25, clinical, sociodemographic, and lifestyle predictors capturing upstream, intermediate, or surrogate factors associated with MASLD progression and mortality were considered. The cohorts were split into 75% training and 25% testing, and 5-fold cross-validation was used for hyperparameter tuning. Evaluation was performed in the held-out test set using the Concordance index (C-Index), integrated Brier score (iBS), time-dependent area under the curve (AUC(t)), and visual calibration plots. Important predictors were described based on global importance and directionality of Shapley additive explanation values. Results: Of 30,097 participants, we identified 8,429 with MASLD (35.3% female) followed for a median of 7.67 years (IQR: 6.84, 8.45), of which 631 (7.5%) died. Using a random survival forest model, all-cause mortality risk prediction demonstrated meaningful stratification across the follow-up period (Females: C-Index 0.73, iBS 0.032, mean AUC(t) 0.78; Males: C-Index 0.79, iBS 0.035, mean AUC(t) 0.82). Risk prediction profiles for females and males differed. Alongside clinical factors such as albumin and cardiometabolic multimorbidity, female risk was impacted by income, education, and lifestyle, particularly in middle-age. Comparatively, metabolic parameters such as waist circumference, blood pressure, albumin, and body mass index were important predictors for males. Conclusion: Our findings describe how mortality risk prediction profiles for people with MASLD vary by sex and age. This highlights the potential value of integrating SDoHs into sex-specific prognostication, bridging social and precision medicine to enable more equitable, individualized risk prediction in MASLD.

  • Open Access

    Females at the intersection: Housing instability, drug use, and syphilis risk among street-involved populations in Ontario, Canada

    by Lucy Mackrell, Megan Carter, Jillian P. Antoun, Hugh Guan, Piotr Oglaza, Bradley Stoner, Patrick O’BYrne, Mary Southall, Tejan Baldeh, Natasha Larkin, et al.

  • Open Access

    Evaluation of a Real‐Time Knowledge Exchange Network Supporting Syphilis Rapid Testing and Immediate Treatment in Seven Public Health Units in Ontario, Canada

    by Megan Ann Carter, Sara Tryon, Mary Southall, Kandace Belanger, Mary France Caron‐Bruneau, Anne Charron, Sandra Dereski, Michael Evans, Natasha Larkin, Kassandra Plante, et al.

    Introduction: The Syphilis Point of care Rapid testing and Immediate Treatment Evaluation (SPRITE) is a collaborative, community‐based initiative that strengthens syphilis prevention and control in Ontario, Canada through flexible outreach nursing and point‐of‐care testing (POCT) and immediate treatment. Seven public health units (PHUs) partnered with 86 community‐based organizations (CBOs) to deliver syphilis/HIV POCTs in underserved settings. This study evaluated a real‐time knowledge exchange network that supported syphilis POCT implementation and capacity‐building across PHUs and CBOs in Ontario. Methods: The evaluation was a mixed‐methods case study using surveys and interviews focusing on the community of practice (CoP), community engagement, and knowledge mobilization. It considers SPRITE CoP activities from beginning of implementation (mid 2023) to the Fall of 2025. Results: The CoP, consisting of public health nurses, researchers, and knowledge specialists, supported engagement, co‐development, and peer learning. Members shared lessons learned, built partnerships, and supported each other in navigating challenges. Flexibility in funding allowed innovation by CoP members in their CBO engagement efforts but also created some uncertainty and possible confusion. CoP members were overall satisfied with CoP functioning, and CBOs surveyed appeared knowledgeable and engaged in SPRITE. Discussion: The CoP model, while distinct from traditional public health CoPs, proved effective in fostering engagement, resource development, and knowledge mobilization. Lessons learned and tools developed provide guidance for future POCT efforts. Improvements should include clearer goals, stronger facilitation, and structured engagement strategies. Addressing funding stability, particularly for POCT services and CoP management roles, is essential. Strengthening CBO partnerships through incentives and bi‐directional information sharing will further enhance POCT and syphilis prevention. This evaluation underscores the importance of flexible yet accountable approaches to knowledge mobilization and POCT implementation in diverse public health contexts. Continued investment in collaborative networks like SPRITE remains critical to advancing syphilis elimination efforts across Ontario.

  • Open Access

    Time‐Varying Impact of Steatosis and Alcohol on Mortality: A Marginal Structural Model of the Canadian Longitudinal Study on Aging

    by Carmela Rapino, Giada Sebastiani, Jessica Burnside, Cindy Wen, Alnoor Ramji, Mark Swain, Keyur Patel, Sahar Saeed

    Background and Aims: Subclassifications of steatotic liver disease (SLD) are intended to provide a clinically meaningful framework for management. However, steatosis, cardiometabolic comorbidities and alcohol consumption are known to change over time. We investigated the association of the dynamic classification of SLD subtypes and all‐cause mortality. Methods: We analysed data from the Canadian Longitudinal Study on Aging, a cohort of adults aged 45–85 years that is followed every 3 years or until death. Hepatic steatosis was identified using the NAFLD Ridge Score, and alcohol consumption was used to classify MASLD, MetALD and ALD. Marginal structural Cox proportional hazards models estimated associations between time‐varying SLD subtypes and mortality. Models were adjusted for socio‐demographic, lifestyle and cardiometabolic factors, and stratified by sex. Results: Among 16 560 participants (52.1% female; median age 58 [IQR 51–66] years), 1041 deaths occurred within a median of 7.8 years. Within the first 3 years, 35.4%, 23.7% and 22.6% of participants with ALD, MetALD and MASLD, respectively, transitioned to different SLD subtypes. Mortality risk increased with increasing levels of alcohol among people with and without steatosis, and ALD demonstrated the highest mortality risk (aHR 6.11; 95% CI 1.76–21.19). Sex‐stratified analyses suggested higher mortality among females, with the highest mortality rate in females with ALD compared to males (11.37 vs. 5.60 per 1000 person‐years). Conclusions: SLD phenotypes are dynamic, with substantial transitions between disease subtypes over time. Reliance on static classifications may therefore misclassify risk. Longitudinal, time‐varying approaches better capture disease evolution and may improve prognostic assessment and risk stratification.

  • Open Access

    Correction: Reimbursement restrictions reduce liver fibrosis screening in adults with diabetes in Ontario: a population-based interrupted time series analysis

    by Jessica Burnside, Maya Djerboua, Jennifer A. Flemming, Giada Sebastiani, William W. L. Wong, Zihang Lu, Harpreet S. Bajaj, Keyur Patel, Mia Biondi, Michael Betel, et al.

  • Open Access

    Expanding the reach of pre-exposure prophylaxis services in suburban and rural Ontario: an implementation science evaluation of a public health-led model

    by Carmela Rapino, Emma Nagy, Sahar Saeed, Beatriz Alvarado, Nicole Szumlanski, Miriam Kamotho, T. Hugh Guan, Jorge Martinez-Cajas

    Despite the proven efficacy of pre-exposure prophylaxis (PrEP) in preventing HIV, disparities among service delivery prevail in Canada, particularly among suburban and rural regions. This study evaluates the reach and effectiveness of a mixed-service delivery PrEP clinic embedded within a public health unit, located in Southeastern Ontario. The PrEP clinic possesses an interdisciplinary team that delivers in-person and remote services. In consultation with PrEP clinic staff, we used the RE-AIM Framework to describe client characteristics (reach) and evaluate implementation effectiveness across the continuum of care, leveraging client electronic medical records. Between 2018 and 2024, 141 clients engaged in PrEP services, the majority of whom were cisgender men (97.2%) with a median age of 37 years. Of those assessed, 70% (n = 98) initiated PrEP. Initiation was more likely among clients living outside the catchment area (RR = 1.35, 95% CI: 1.11-1.64), those with a history of hepatitis B (RR = 1.45, 95% CI: 1.30-1.62), and those reporting a history of having an HIV-positive partner (RR = 1.33, 95% CI: 1.18-1.49). The median duration of engagement was 8 months (IQR: 3-21 months), with no new HIV diagnoses reported. Overall, 54.1% of clients disengaged (n = 53), with the highest rates occurring within the first 3 months and after 12 months. Common reasons for disengagement included transferring care (24.5%), moving (18.9%), and changes in sexual activity (16.98%). This evaluation demonstrates that mixed-service public-health led PrEP delivery models can effectively engage clients in suburban and rural settings. Findings support the scalability of flexible, public health led approaches to expanding equitable access to PrEP in Canada.

  • Open Access

    Uptake of prenatal syphilis screening and its determinants in Ontario, Canada: a population-based retrospective cohort study

    by Amanda Featherstone, Hannah Willms, Maria B. Ospina, Maria P. Velez, Megan Carter, Zoë R. Greenwald, Melissa Richard-Greenblatt, Sophie Yee, Jennifer Flemming, Sahar Saeed

    Timely prenatal syphilis screening is critical for preventing congenital syphilis infection. We aimed to examine prenatal syphilis screening patterns in Canada and to identify factors associated with missed or late screening. For this population-based retrospective cohort study, we used linked provincial administrative health data from Ontario, Canada. We included pregnancies (> 20 wk gestation) resulting in live births or stillbirths from January 2018 to December 2023. Missed prenatal syphilis screening (at any point during pregnancy or at delivery) or late screening (either during the third trimester or at delivery) were the primary outcomes. We evaluated individual-level and external factors associated with the outcomes using modified Poisson regressions with generalized estimating equations. We reported adjusted relative risks (RRs) and 95% confidence intervals (CIs). Among 551 706 pregnancies (median maternal age 31 yr, interquartile range 28 to 34 yr), 507 169 (91.9%) were screened for syphilis, and 435 162 (78.9%) received first-trimester screening. Screening rates increased over time and varied by geography and individual risk factors. Those tested for syphilis within 1 year before conception were more likely to miss screening during pregnancy (adjusted RR 2.12, 95% CI 2.08 to 2.16). Initial screening at delivery was associated with being younger (15 to 19 yr v. 30 to 39 yr) at conception (adjusted RR 4.01, 95% CI 3.33 to 4.81), having injection or general drug use within 3 years before conception (adjusted RR 3.78, 95% CI 3.11 to 4.59), and living in a neighbourhood of the lowest income quintile (adjusted RR 1.59, 95% CI 1.40 to 1.80). Similar factors were associated with initial screening during the third trimester. In Ontario, 1 in 5 pregnancies did not receive timely first-trimester screening for syphilis, and we identified sociodemographic and behavioural factors associated with late screening. These findings point to modifiable gaps in system and service delivery and highlight the need for coordinated clinical, public health, and community-based strategies to improve coverage and timeliness of prenatal syphilis screening.


  • Open Access

    Reimbursement restrictions reduce liver fibrosis screening in adults with diabetes in Ontario: a population-based interrupted time series analysis

    by Jessica Burnside, Maya Djerboua, Jennifer A. Flemming, Giada Sebastiani, William W. L. Wong, Zihang Lu, Harpreet S. Bajaj, Keyur Patel, Mia Biondi, Michael Betel, et al.

    Adults with type 2 diabetes have increased risk of liver fibrosis, leading guidelines to recommend screening with the Fibrosis-4 Index (FIB-4). We assessed if modifications to Ontario Health Insurance Plan coverage of aspartate aminotransferase (AST) tests in 2013 were associated with changes in liver fibrosis assessment rates among adults with diabetes. This population-based cohort study included adults with diabetes and no history of liver disease in Ontario, Canada, from 2010 to 2022. Policy periods were constructed based on AST reimbursement practices. The primary outcome was the receipt of all laboratory tests needed to calculate FIB-4 (AST, alanine aminotransferase, and platelet count). Modified Poisson regression estimated the adjusted risk ratios (aRRs) for predictors of receiving liver fibrosis assessment. Interrupted time series analysis employed autoregressive integrated moving average models to assess both immediate and sustained policy effects. This study included 1,680,451 individuals; 47% were female; median age was 64 years [IQR, 55–73 years]. The annual proportion without any testing ranged from 39 to 47%. The risk of receiving all required tests for FIB-4 declined significantly: 12.7% (aRR 0.873, 0.869–0.877) during implementation, 33.9% (aRR 0.661, 0.657–0.664) post-intervention, and 63.1% (aRR 0.369, 0.366–0.371) COVID-19. Interrupted time-series analysis showed a significant immediate decline in monthly testing of FIB-4 components (− 0.38; 95% CI − 0.59 to − 0.18), followed by a continued monthly decrease (− 0.03; 95% CI − 0.07 to 0.01). Restricting AST reimbursement was associated with a decline in liver fibrosis assessments for people with diabetes despite increasing consensus in favor of preventative screening.

  • Impact of Patient Navigation on Time to Treatment Among Patients With GI Cancers at Rwanda Military Referral and Teaching Hospital

    by Vincent Kwizera, Costas Chavarri Aihnoa, Kenneth Kiiza Rutikanga, Jovia Kakwezi, Marthe Nyiraneza, Alain Fabrice Mizero, Isabelle Mutetiwabo, Christine Izabiriza, Eulade Rugengamanzi, Sahar Saeed, et al.

    PURPOSE: To evaluate the impact of a patient navigation program (PNP) on treatment delays among patients with GI cancers at the Rwanda Military Referral and Teaching Hospital (RMRTH). METHODS: PNP is a personalized support model implemented at RMRTH on April 1, 2023, to guide patients with a cancer diagnosis through the health care system. We used a quasi-experimental study design and included all patients diagnosed and treated for esophageal, gastric, or colorectal cancer in pre- and postimplementation of PNP at RMRTH. The outcomes of interest were measured in days: treatment interval from pathology report to treatment initiation. Data were abstracted from patients' medical records and analyzed using STATA version 19. The Wilcoxon rank-sum test was performed. Treatment intervals were used in the time series analysis, and the Dickey-Fuller Test was used to test stationarity. RESULTS: A total of 151 patients, with 85 patients in the post-PNP group, were included. The mean age (years) at diagnosis was similar (59.4 ± 13.5 years in the pre-PNP and 59 ± 14.18 years in the post-PNP group). Most patients (80.0% pre-PNP group and 80.9% post-PNP group) presented with stage III/IV. Neoadjuvant chemotherapy was the most common initial treatment (48.5% pre-PNP and 54.1% post-PNP). The median treatment interval decreased from 53.5 days (IQR, 26-129) in the pre-PNP group to 32 days (IQR, 14-63) in the post-PNP group ( P < .001). The reductions in treatment delays were significant over time following the implementation of the PNP ( P = .004). CONCLUSION: PNP reduced treatment delays among patients with GI cancers at RMRTH. Despite the important findings, some limitations remain; hence, further studies are recommended to provide more comprehensive evidence. Integrating PNP into national cancer control strategies is essential to strengthen care coordination and ensure timely access to cancer treatment in low-resource settings like Rwanda.